{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:02:33Z","timestamp":1784307753610,"version":"3.55.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with motor neuron degeneration, progressive paralysis and finally death. Despite the research efforts, currently there is no cure for ALS. In recent years, multiple epigenetic mechanisms have been associated with neurodegenerative diseases. A pathological role for histone hypoacetylation and the abnormal NF-\u03baB\/RelA activation involving deacetylation of lysines, with the exclusion of lysine 310, has been established in ALS. Recent findings indicate that the pathological acetylation state of NF-\u03baB\/RelA and histone 3 (H3) occurring in the SOD1(G93A) murine model of ALS can be corrected by the synergistic combination of low doses of the AMP-activated kinase (AMPK)-sirtuin 1 pathway activator resveratrol and the histone deacetylase (HDAC) inhibitors MS-275 (entinostat) or valproate. The combination of the epigenetic drugs, by rescuing RelA and the H3 acetylation state, promotes a beneficial and sexually dimorphic effect on disease onset, survival and motor neurons degeneration. In this mini review, we discuss the potential of the epigenetic combination of resveratrol with HDAC inhibitors in the ALS treatment.<\/jats:p>","DOI":"10.3389\/fphar.2022.1017364","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T04:40:02Z","timestamp":1666327202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Edoardo","family":"Parrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Porrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Scambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gussago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwamolakun","family":"Bankole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Benarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/ijms23031047","article-title":"Beneficial and sexually dimorphic response to combined HDAC inhibitor valproate and AMPK\/SIRT1 pathway activator resveratrol in the treatment of ALS mice","volume":"23","author":"Bankole","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.freeradbiomed.2009.01.019","article-title":"An in vitro screening cascade to identify neuroprotective antioxidants in ALS","volume":"46","author":"Barber","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2020.00068","article-title":"Nucle-ar factor-\u03bab dysregulation and \u03b1-synuclein pathology: Critical interplay in the pathogenesis of Parkinson's disease","volume":"12","author":"Bellucci","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/21678421.2020.1779298","article-title":"Focus on the heterogeneity of amyotrophic lateral sclerosis","volume":"21","author":"Bendotti","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: A role for histone post-translational modifications in neurodegenerative disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/17482968.2012.706303","article-title":"Amyotrophic lateral sclerosis: A hormonal condition?","volume":"13","author":"Blasco","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"B7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ebiom.2019.02.039","article-title":"The dark side of HDAC inhibition in ALS","volume":"41","author":"Boutillier","year":"2019","journal-title":"EBioMedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuroscience.2018.03.022","article-title":"Effects of class II-selective histone deacetylase inhibitor on neuromuscular function and disease progression in SOD1-ALS mice","volume":"379","author":"Buonvicino","year":"2018","journal-title":"Neuroscience"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.3390\/ijms222011224","article-title":"Histone deacetylase inhibition regulates lipid home-ostasis in a mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Burg","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fphys.2020.00063","article-title":"Antioxidant alternatives in the treatment of amyotrophic lateral sclerosis: A comprehensive review","volume":"11","author":"Carrera-Juli\u00e1","year":"2020","journal-title":"Front. Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acschemneuro.7b00297","article-title":"Neurodegenerative disease proteinopathies are connected to distinct histone post-translational modification landscapes","volume":"9","author":"Chen","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrm1368","article-title":"Shaping the nuclear action of NF-kappaB","volume":"5","author":"Chen","year":"2004","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","article-title":"Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3","volume":"15","author":"Chen","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implica-tions","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/mus.21260","article-title":"Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis","volume":"39","author":"Crochemore","year":"2009","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17482960802320487","article-title":"Phase 2 study of sodium phenylbutyrate in ALS","volume":"10","author":"Cudkowicz","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"B19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neubiorev.2021.06.027","article-title":"Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact","volume":"127","author":"De Marchi","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17482960802226148","article-title":"Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice","volume":"10","author":"Del Signore","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"B21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/mus.26620","article-title":"Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence","volume":"60","author":"Dios","year":"2019","journal-title":"Muscle Nerve"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1523\/JNEUROSCI.0536-20.2020","article-title":"Mitigation of ALS pathology by neuron-specific inhibition of nuclear factor kappa B signaling","volume":"40","author":"Dutta","year":"2020","journal-title":"J. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","article-title":"Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics","volume":"3","author":"Eberharter","year":"2002","journal-title":"EMBO Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E172","DOI":"10.3390\/ijms19010172","article-title":"Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke","volume":"19","author":"Faggi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e106177","DOI":"10.15252\/embj.2020106177","article-title":"HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations","volume":"40","author":"Fazal","year":"2021","journal-title":"EMBO J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"B28","doi-asserted-by":"publisher","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease","volume":"104","author":"Ghosh","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1600-065X.2012.01096.x","article-title":"NF-\u039aB: Where did it come from and why?","volume":"246","author":"Gilmore","year":"2012","journal-title":"Immunol. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuropharm.2012.05.018","article-title":"Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis","volume":"66","author":"Giribaldi","year":"2013","journal-title":"Neuropharmacology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.can-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tins.2011.03.001","article-title":"Regulation of neural process growth, elaboration and structural plasticity by NF-\u03baB","volume":"34","author":"Gutierrez","year":"2011","journal-title":"Trends Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12929-022-00785-3","article-title":"Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis","volume":"29","author":"Gyawali","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.brainres.2012.09.022","article-title":"Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice","volume":"1483","author":"Han","year":"2012","journal-title":"Brain Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1523\/JNEUROSCI.3052-08.2008","article-title":"Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons","volume":"28","author":"Hasegawa","year":"2008","journal-title":"J. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/jnnp.2011.244939","article-title":"Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology","volume":"82","author":"Huisman","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.celrep.2015.06.019","article-title":"The regulatory machinery of neurodegeneration in in vitro models of amyotrophic lateral sclerosis","volume":"12","author":"Ikiz","year":"2015","journal-title":"Cell. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.1523\/JNEUROSCI.3670-06.2006","article-title":"Bim and Noxa are candidates to mediate the deleterious ef-fect of the NF-kappa B subunit RelA in cerebral ischemia","volume":"26","author":"Inta","year":"2006","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/NEN.0b013e3181ddd404","article-title":"Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis","volume":"69","author":"Janssen","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3390\/ijms17122129","article-title":"Downregulation of homer1b\/c in SOD1 G93A models of ALS: A novel mechanism of neuroprotective effect of lithium and valproic acid","volume":"17","author":"Jiang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ana.20379","article-title":"Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis","volume":"57","author":"Jiang","year":"2005","journal-title":"Ann. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-3-319-53889-1_14","article-title":"Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis","volume":"978","author":"Jimenez-Pacheco","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/npp.2013.207","article-title":"Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability","volume":"39","author":"Jochems","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.3390\/ijms22083875","article-title":"The links between ALS and NF-\u03baB","volume":"22","author":"K\u00e4llstig","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnmol.2015.00069","article-title":"NF-KappaB in long-term memory and structural plasticity in the adult mammalian brain","volume":"24","author":"Kaltschmidt","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/bph.15217","article-title":"Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis","volume":"178","author":"Klingl","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","article-title":"Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders","volume":"66","author":"Konsoula","year":"2012","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2174\/1381612821666150105160059","article-title":"Phenylbutyric acid: Simple structure - multiple effects","volume":"21","author":"Kusaczuk","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/s0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis\/Riluzole Study Group II","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2012.08.018","article-title":"Targeted acetylation of NF-kappaB\/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window","volume":"49","author":"Lanzillotta","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fneur.2015.00098","article-title":"NF-\u03baB in innate neuroprotection and age-related neurodegenerative diseases","volume":"6","author":"Lanzillotta","year":"2015","journal-title":"Front. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1038\/cddis.2010.76","article-title":"The acetylation of RelA in Lys310 dictates the NF-\u03baB-dependent response in post-ischemic injury","volume":"1","author":"Lanzillotta","year":"2010","journal-title":"Cell. Death Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neulet.2017.07.033","article-title":"Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice","volume":"656","author":"Lapucci","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fncel.2013.00243","article-title":"Histone deacetylases and their role in motor neuron degeneration","volume":"7","author":"Lazo-G\u00f3mez","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5483\/BMBRep.2019.52.1.290","article-title":"Sirtuin signaling in cellular senescence and aging","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/biom12020333","article-title":"Butyrate ameliorates mitochondrial respiratory capacity of the motor-neuron-like cell line NSC34-g93a, a cellular model for ALS","volume":"12","author":"Li","year":"2022","journal-title":"Biomolecules"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1021\/jm049002a","article-title":"Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides","volume":"48","author":"Mai","year":"2005","journal-title":"J. Med. Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","article-title":"Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice","volume":"11","author":"Mancuso","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/17482961003610853","article-title":"The sex ratio in amyotrophic lateral sclerosis: A population based study","volume":"11","author":"Manjaly","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/jmf.2009.0243","article-title":"A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Markert","year":"2010","journal-title":"J. Med. Food"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"ALS genetics, mechanisms, and therapeutics: Where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"CD001447","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"2012","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/bjh.12388","article-title":"Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC","volume":"162","author":"Mithraprabhu","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(14)70129-2","article-title":"Clinical trials in amyotrophic lateral sclerosis: Why so many negative tri-als and how can trials be improved?","volume":"13","author":"Mitsumoto","year":"2014","journal-title":"Lancet. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12974-020-02028-4","article-title":"Neuroprotective epi-drugs quench the inflammatory response and microglial\/macrophage activation in a mouse model of permanent brain ischemia","volume":"17","author":"Mota","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/antiox10081328","article-title":"Therapeutic potential of polyphenols in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"10","author":"Novak","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ensci.2018.05.001","article-title":"Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis","volume":"11","author":"Okada","year":"2018","journal-title":"eNeurologicalSci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfl068","article-title":"The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro","volume":"93","author":"Olaharski","year":"2006","journal-title":"Toxicol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: An update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"B73","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/1673-5374.317957","article-title":"Deciphering the role of PGC-1\u03b1 in neurological disorders: From mitochondrial dysfunction to synaptic failure","volume":"17","author":"Panes","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/nu13010085","article-title":"From preclinical stroke models to humans: Polyphenols in the prevention and treatment of stroke","volume":"13","author":"Parrella","year":"2020","journal-title":"Nutrients"},{"key":"B75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s13311-014-0311-0","article-title":"Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Patel","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experi-ence","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"B77","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.21620","article-title":"Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis","volume":"66","author":"Piepers","year":"2006","journal-title":"Ann. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","article-title":"Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis","volume":"40","author":"Pigna","year":"2019","journal-title":"EBioMedicine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1046\/j.1460-9568.2002.02403.x","article-title":"Expression of functional NR1\/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line","volume":"16","author":"Pizzi","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.cdd.4401598","article-title":"NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity","volume":"12","author":"Pizzi","year":"2005","journal-title":"Cell. Death Differ."},{"key":"B82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2014.03.005","article-title":"Endoplasmic reticulum stress is accompanied by activation of NF-\u03baB in amyotrophic lateral sclerosis","volume":"270","author":"Prell","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/10408444.2020.1762538","article-title":"The estrogenic activity of resveratrol: A comprehensive review of in vitro and in vivo evidence and the potential for endocrine disruption","volume":"50","author":"Qasem","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10571-010-9518-8","article-title":"Modulation of synaptic transmission and analysis of neuroprotective effects of valproic Acid and derivates in rat embryonic motoneurons","volume":"30","author":"Ragancokova","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874375701004010011","article-title":"p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS","volume":"4","author":"Ranganathan","year":"2010","journal-title":"Open Pathol. J."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1039\/c7fo01300k","article-title":"A comprehensive review of the health perspectives of resveratrol","volume":"8","author":"Rauf","year":"2017","journal-title":"Food Funct."},{"key":"B87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40478-019-0750-2","article-title":"Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model","volume":"7","author":"Rossaert","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","article-title":"Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Rouaux","year":"2007","journal-title":"J. Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: A long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03447.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J. Neurochem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41419-020-2580-3","article-title":"HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo","volume":"11","author":"Sanna","year":"2020","journal-title":"Cell. Death Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.brainres.2012.04.013","article-title":"NF-\u03baB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress","volume":"1476","author":"Sarnico","year":"2012","journal-title":"Brain Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00702-007-0007-2","article-title":"Activation of NF-kappaB p65\/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells","volume":"115","author":"Sarnico","year":"2008","journal-title":"J. Neural Transm."},{"key":"B94","doi-asserted-by":"publisher","first-page":"12875","DOI":"10.1038\/s41598-018-30659-4","article-title":"Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model","volume":"8","author":"Schiaffino","year":"2018","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/187152710791292684","article-title":"Histone deacetylation and motor neuron degeneration","volume":"9","author":"Schmalbach","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B96","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/acsmedchemlett.9b00560","article-title":"Structural and in vivo characterization of tubastatin A, a widely used histone deacetylase 6 inhibitor","volume":"11","author":"Shen","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"B97","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation","volume":"11","author":"Shukla","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B99","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1517\/14728222.2014.989834","article-title":"Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pa-thologies of Alzheimer's disease and multiple sclerosis","volume":"19","author":"Srinivasan","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"B100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.reprotox.2013.07.019","article-title":"Valproic acid and its derivatives enhanced estrogenic activity but not androgenic activity in a structure dependent manner","volume":"42","author":"Stempin","year":"2013","journal-title":"Reprod. Toxicol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","article-title":"Benefit of valproic acid in suppressing disease progression of ALS model mice","volume":"20","author":"Sugai","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB-mediated pathogenic pathways","volume":"208","author":"Swarup","year":"2011","journal-title":"J. Exp. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.4103\/1673-5374.303024","article-title":"Histone acetylation and deacetylation in ischemic stroke","volume":"16","author":"Uzdensky","year":"2021","journal-title":"Neural Regen. Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"4390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"bnz005","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"901152","DOI":"10.3389\/fonc.2022.901152","article-title":"Efficacy and safety profile of histone deacetylase inhibitors for metastatic breast cancer: A meta-analysis","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neulet.2011.08.047","article-title":"Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis","volume":"503","author":"Wang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000342156","article-title":"Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment","volume":"40","author":"Wittie","year":"2013","journal-title":"Neuroepidemiology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/med.21661","article-title":"The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future","volume":"40","author":"Wobst","year":"2020","journal-title":"Med. Res. Rev."},{"key":"B110","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial","volume":"16","year":"2017","journal-title":"Lancet. Neurol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2011.09.025","article-title":"CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: Protection by resveratrol but not riluzole","volume":"1423","author":"Y\u00e1\u00f1ez","year":"2011","journal-title":"Brain Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2018.05.004","article-title":"Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-\u03baB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1G93A mutation","volume":"90","author":"Yin","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14737175.2019.1581610","article-title":"Edaravone for the treatment of amyotrophic lateral sclerosis","volume":"19","author":"Yoshino","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/term.2776","article-title":"Reduced sirtuin 1\/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol","volume":"13","author":"Yun","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"112164","DOI":"10.1016\/j.biopha.2021.112164","article-title":"Resveratrol (rv): A pharmacological review and call for further research","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuron.2021.12.019","article-title":"Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis","volume":"110","author":"Zhang","year":"2022","journal-title":"Neuron"},{"key":"B118","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11515-012-1233-z10.1007\/s11515-012-1233-z","article-title":"NF\u03baB signaling regulates embryonic and adult neurogenesis","volume":"7","author":"Zhang","year":"2012","journal-title":"Front. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1017364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T04:40:05Z","timestamp":1666327205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1017364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":118,"alternative-id":["10.3389\/fphar.2022.1017364"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1017364","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"article-number":"1017364"}}